logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Shock

    Medications for Shock

    FiltersReset Filters
    10 results
    • dexamethasone sodium phosphate

      (Dexamethasone Sodium Phosphate)
      Hikma Pharmaceuticals USA Inc.
      Usage: This drug is indicated for intravenous or intramuscular use in various conditions, including endocrine disorders (e.g., adrenal insufficiency), rheumatic disorders (e.g., rheumatoid arthritis), allergic states, skin diseases, and gastrointestinal issues. It also addresses respiratory, hematologic, neoplastic, and nervous system disorders, with specific applications for intra-articular, soft tissue, and intralesional administration.
    • dexamethasone sodium phosphate

      (Dexamethasone Sodium Phosphate)
      Mylan Institutional LLC
      Usage: This drug is indicated for various conditions, including adrenal insufficiencies, rheumatic disorders, collagen diseases, severe allergic reactions, ophthalmic, gastrointestinal, respiratory, hematologic, and neoplastic diseases, and for reducing edema. It can be administered intravenously, intramuscularly, intra-articularly, or intralesionally, depending on the condition.
    • dexamethasone sodium phosphate

      (Dexamethasone Sodium Phosphate)
      Amneal Pharmaceuticals LLC
      Usage: This drug is indicated for various conditions, including endocrine and rheumatic disorders, allergic states, gastrointestinal diseases, respiratory diseases, hematologic disorders, and certain dermatologic and ophthalmic diseases. It can be administered intravenously, intramuscularly, intra-articular, or intralesionally for acute episodes and management of chronic conditions.
    • dexamethasone sodium phosphate

      (Dexamethasone Sodium Phosphate)
      Mylan Institutional LLC
      Usage: This drug is indicated for various conditions including adrenocortical insufficiency, rheumatic and collagen diseases, severe allergic reactions, ophthalmic and respiratory diseases, gastrointestinal diseases, hematologic disorders, neoplastic diseases, and cerebral edema. It can be administered via intravenous, intramuscular, intra-articular, or intralesional injections.
    • dexamethasone sodium phosphate

      (Dexamethasone Sodium Phosphate)
      Somerset Therapeutics, LLC
      Usage: This drug is indicated for intravenous or intramuscular use in endocrine disorders, rheumatic disorders, collagen diseases, dermatologic conditions, severe allergic states, ophthalmic diseases, gastrointestinal and respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, and acute exacerbations of multiple sclerosis, among other conditions.
    • isoproterenol hydrochloride

      (Isoproterenol Hydrochloride)
      Amphastar Pharmaceuticals, Inc.
      Usage: Isoproterenol hydrochloride injection is indicated for mild or transient heart block, serious heart block and Adams-Stokes attacks (excluding ventricular tachycardia), cardiac arrest, bronchospasm during anesthesia, and as an adjunct in treating hypovolemic/septic shock, low cardiac output states, congestive heart failure, and cardiogenic shock.
    • sodium bicarbonate

      (sodium bicarbonate injection,)
      Long Grove Pharmaceuticals, LLC
      Usage: Sodium Bicarbonate Injection is indicated for treating metabolic acidosis in conditions like severe renal disease, uncontrolled diabetes, shock, cardiac arrest, and certain drug intoxications. It helps alkalinize urine in hemolytic reactions and counteracts bicarbonate loss in severe diarrhea, while addressing underlying causes when possible.
    • sodium bicarbonate

      (SODIUM BICARBONATE)
      Hospira, Inc.
      Usage: Sodium Bicarbonate Injection is indicated for treating metabolic acidosis resulting from severe renal disease, shock, diabetic acidosis, or lactic acidosis. It also helps in specific drug intoxications and severe diarrhea, aiding in urine alkalinization to reduce nephrotoxicity. Therapy should complement addressing the acidosis's underlying cause.
    • vasopressin

      (Vasopressin)
      Sagent Pharmaceuticals
      Usage: Vasopressin Injection is used to elevate blood pressure in adults experiencing vasodilatory shock who remain hypotensive despite receiving fluids and catecholamines.
    • vasopressin

      (VASOPRESSIN)
      Fresenius Kabi USA, LLC
      Usage: Vasopressin injection is indicated for increasing blood pressure in adults experiencing vasodilatory shock who do not respond to fluid resuscitation and catecholamine treatment.